Doctors warned patients to tell that powerful asthma drug montelukast can cause suicidal thoughts

Doctors warned to tell patients that powerful asthma drug montelukast can cause suicidal thoughts or hallucinations

  • Many patients said that montelukast had deeply influenced their behavior
  • They complained about nightmares and also saw grotesque things while they were awake
  • It is extremely effective in reducing the frequency of serious asthma attacks
Advertisements

Doctors have been warned to tell patients that a powerful asthma drug can cause suicidal thoughts or hallucinations.

Official advice from the medication regulator is a victory for The Mail on Sunday, after we revealed that many patients, including children, said that montelukast had profoundly influenced their behavior.

They complained about nightmares, saw grotesque things while they were awake, and were caught by suicidal urges after taking the drug, also known as Singulair.

Official advice from the medication regulator is a victory for The Mail on Sunday, after we revealed that many patients, including children, said that montelukast had profoundly influenced their behavior (file image)

Advertisements

Official advice from the medication regulator is a victory for The Mail on Sunday, after we revealed that many patients, including children, said that montelukast had profoundly influenced their behavior (file image)

It is extremely effective in reducing the frequency of severe asthma attacks and is also used to combat hay fever.

But now the Regulatory Agency Medicines and Healthcare Products has published a safety update as a reminder of the & # 39; risk of neuropsychiatric reactions & # 39 ;.

It says: & Prescribers must carefully consider the benefits and risks of continuing treatment if they occur. & # 39;

After our first story was published in May, dozens of people contacted the MoS to describe their trials.

Many complained that they had never been warned by their doctor about the risks. Some said when they came back to tell about their terrible experiences, their fear that the drug was responsible was taken away.

The MHRA warning urges health professionals to inform patients about potential problems and says they should advise & # 39; patients and their caregivers to carefully read the list of neuropsychiatric reactions in the package leaflet and seek medical help immediately if: they occur & # 39 ;.

Advertisements

However, it also emphasized in patients: & # 39; It is important that you do not stop taking montelukast without first talking to a doctor or asthma nurse. & # 39;

This is because releasing medication can lead to the resumption of serious asthma attacks.

. (TagsToTranslate) Dailymail (t) health

- Advertisement -